Medical Devices Startups

Ally Bridge Group is a healthcare investment management firm investing across the global life sciences industry through complementary private equity and public equity strategies. It operates across the capital structure with offices in New York and Hong Kong, serving investors seeking exposure to healthcare innovation.

1 investor

Alma develops medical aesthetic and healthcare technology platforms including lasers and treatment devices designed to deliver safe and effective treatments for patients. The company serves aesthetic practitioners, clinics, and medical professionals globally.

1 investor

Alpenglow Biosciences develops AI-enabled 3D tissue imaging and spatial profiling platforms for researchers and clinical teams in pathology and diagnostics. The company's patented light-sheet microscopy technology provides volumetric tissue data for analysis and clinical discovery applications.

1 investor

A biopharmaceutical company developing oncology treatments including EGFR-targeting small molecule drugs for lung cancer with CNS penetration, and expanding into cell immunotherapy through licensed partnerships for NK cell and CAR-T therapies targeting solid tumors and hematologic malignancies.

1 investor

ATEC Spine develops surgical devices and approaches for spine surgery, targeting decompression, stabilization, and alignment for surgeons treating spinal pathologies. The company operates in the medical technology sector focused on spine surgery.

1 investor

Alphyn Biologics develops Multi-Target Therapeutics based on its Zabalafin (AB-101) platform to treat skin diseases, with a lead candidate, zabalafin hydrogel, a non-steroidal topical treatment for atopic dermatitis in children and adults that targets itch, inflammation, and Staph bacteria. The company operates in the biotech/dermatology drug development sector and has completed a Phase 2a clinical trial.

1 investor

Alpinasana develops foods for special medical purposes (medical nutrition products such as drink meals, ice cream, soups and baked goods) alongside an automated nutrition-tracking scanner that logs patients' food intake into hospital information systems. It targets hospitals and care homes in Switzerland to detect and address malnutrition among patients and elderly residents.

1 investor

Alsteni Medical develops an intraoral gastrointestinal access device designed to deliver nutrient therapy for metabolic management. The company is advancing the device through FDA 510(k) clearance with clinical evidence and manufacturing partnerships in place.

1 investor

Altach Biomedical develops cartilage repair solutions for the orthopedic medical device industry. The company showcases its innovative technologies at major MedTech conferences to engage with investors and strategic partners.

1 investor

Altamash General Hospital is a 260-bed multi-specialty hospital offering medical and surgical departments, diagnostic imaging (X-ray, CT, MRI, ultrasound, endoscopy), a clinical laboratory, 24-hour emergency care, ICU/NICU, and pharmacy services. Located in Clifton, Karachi, it serves patients across Pakistan and grew out of Dr. Altamash's dental care practice.

1 investor

Alta Partners is a venture capital firm focused on life sciences and healthcare investments, with a portfolio that has generated over 90 FDA-approved products and includes both therapeutic companies and tech-enabled patient care services.

1 investor

AlterDiag is a diagnostics company founded by executives with backgrounds in immunology R&D and business strategy. The page focuses on the founding team and does not detail the specific product beyond its work in the diagnostics market.

1 investor

AlterG develops anti-gravity treadmill systems using patented Differential Air Pressure technology to enable rehabilitation and athletic training. The systems serve orthopedic rehabilitation, neurological condition management, active aging, and athletic performance improvement.

1 investor

Altratech develops point-of-care diagnostic technology for quantitative HIV viral load testing in low- and middle-income countries. The company creates affordable and accessible medical devices for resource-limited healthcare settings.

1 investor

Altum Sequencing develops molecular sequencing assays for oncology programs, supporting pharmaceutical companies and healthcare providers in biomarker strategy, companion diagnostic development, and post-approval patient monitoring in cancer treatment.

1 investor

Altus designs and manufactures mobile workstations, wall mounts, IoT-enabled carts, and OEM-integrated healthcare equipment for clinical and IT teams. The company produces all solutions in Michigan with locally sourced components.

1 investor

Aluna Data provides a benchmarking suite for oncology AI models, offering standardized datasets including over 2 million whole slide images across 25+ tumor types with pathologist annotations, whole genome sequencing data, and clinical information for cancer research and AI development.

1 investor

Alva Health develops wearable medical devices that continuously monitor for early signs of stroke and alert emergency responders in real time. The company serves patients at risk of stroke and the healthcare system, focusing on improving outcomes through rapid detection and treatment initiation.

1 investor

AlveoGene develops respiratory gene therapies, led by executives and academic researchers from the UK Respiratory Gene Therapy Consortium.

1 investor

ALVO Medical manufactures modular medical enclosure systems with materials including stainless steel, glass, and HPL panels designed for operating rooms and healthcare facilities. The company emphasizes durability, hygiene, and aesthetic design aligned with healing-focused interior concepts.

1 investor

Alvogen is a pharmaceutical company committed to making high-quality medicines more accessible through a focus on best people, portfolio, service, quality, and cost efficiency. The company serves customers globally in the pharmaceutical industry.

1 investor

Alydia Health manufactures the JADA System, an intrauterine device that uses low-level vacuum to control postpartum hemorrhage in hospital settings. The device is designed for rapid bleeding control in obstetric care and is used across more than 2,000 U.S. hospitals.

1 investor

Alyf develops AI-native heart care technology built by physicians to surface hidden cardiac signals and guide clinical action. The platform is currently deployed with leading medical centers and expanding access through 2026-2027.

1 investor

American-Sino (美华) operates private hospitals and clinics in Shanghai, including a women's and children's hospital, medical centers, pediatric and maternity care facilities. It provides medical services across departments such as obstetrics and gynecology, pediatrics, dermatology, dentistry, traditional Chinese medicine, and general practice.

1 investor